These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 915835)

  • 1. Action of oleic acid on the exocrine pancreatic secretion of the conscious rat: evidence for an anti-cholecystokinin-pancreozymin factor.
    Laugier R; Sarles H
    J Physiol; 1977 Sep; 271(1):81-92. PubMed ID: 915835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of secretin and cholecystokinin in oleic acid-stimulated pancreatic secretion in rats.
    Shiratori K; Watanabe S; Takeuchi T; Shimizu K; Moriyoshi Y
    Gastroenterol Jpn; 1990 Feb; 25(1):104-11. PubMed ID: 1689684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCK and PYY do not participate in the delayed inhibition of pancreatic secretion, after stimulation by duodenal oleic acid infusion.
    Issoual D; Berger Z; Laugier R
    Regul Pept; 1991 Oct; 36(1):45-57. PubMed ID: 1796181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats.
    Li P; Lee KY; Chang TM; Chey WY
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G960-5. PubMed ID: 2260665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pancreatic juice and trypsin on oleic acid-stimulated pancreatic secretion and plasma secretin in dogs.
    Shiratori K; Jo YH; Lee KY; Chang TM; Chey WY
    Gastroenterology; 1989 May; 96(5 Pt 1):1330-6. PubMed ID: 2703117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of the cholecystokinin antagonist loxiglumide on pancreatic exocrine secretion and pancreatic growth in conscious rats.
    Taguchi S; Green GM; Nakano I; Hatta Y
    Int J Pancreatol; 1992 Apr; 11(2):67-73. PubMed ID: 1607730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of fatty acids on the exocrine pancreatic secretion of the conscious rat: further evidence for a protein pancreatic inhibitory factor.
    Demol P; Sarles H
    J Physiol; 1978 Feb; 275():27-37. PubMed ID: 633115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of intraduodenal administration of somatostatin analogue SDZ CO 611 on rat pancreatic exocrine secretion.
    Shiratori K; Watanabe S; Takeuchi T
    Pancreas; 1993 Jul; 8(4):471-5. PubMed ID: 8361968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oleate on pancreatic and bile secretion in the conscious rat.
    Miyasaka K; Kitani K
    Proc Soc Exp Biol Med; 1988 Oct; 189(1):94-9. PubMed ID: 3186767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of natural peptide YY on pancreatic secretion and cholecystokinin release in conscious dogs.
    Hosotani R; Inoue K; Kogire M; Tatemoto K; Mutt V; Suzuki T; Rayford PL; Tobe T
    Dig Dis Sci; 1989 Mar; 34(3):468-73. PubMed ID: 2920652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous and endogenous stimulations during different phases of pancreatic secretion in conscious rats.
    Pap A; Lechene de la Porte P; Sarles H
    Pflugers Arch; 1979 Dec; 383(1):19-27. PubMed ID: 574944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of neurotensin and fat on pancreatic stimulation in dogs.
    Konturek SJ; Jaworek J; Cieszkowski M; Pawlik W; Kania J; Bloom SR
    Am J Physiol; 1983 Jun; 244(6):G590-8. PubMed ID: 6305210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of caerulein on pancreatic secretion of the dog and biliary secretion of the dog and the rat.
    Bertaccini G; De Caro G; Endean R; Erspamer V; Impicciatore M
    Br J Pharmacol; 1969 Sep; 37(1):185-97. PubMed ID: 5824930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luminal bile regulates cholecystokinin release in conscious rats.
    Nakamura R; Miyasaka K; Kuyama Y; Kitani K
    Dig Dis Sci; 1990 Jan; 35(1):55-60. PubMed ID: 2295295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of rat pancreatic secretion by neurotensin: mechanism of action.
    Demol P; Laugier R; Dagorn JC; Sarles H
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):139-48. PubMed ID: 94530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valsartan, a specific angiotensin II receptor blocker, inhibits pancreatic fluid secretion via vagal afferent pathway in conscious rats.
    Yamamoto M; Wei L; Otani M; Harada M; Otsuki M
    Regul Pept; 2012 Oct; 178(1-3):80-5. PubMed ID: 22796317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term bile diversion enhances basal and duodenal oleate-stimulated pancreatic exocrine secretion in dogs.
    Takahashi M; Naito H; Sasaki I; Funayama Y; Shibata C; Matsuno S
    Tohoku J Exp Med; 2004 Jun; 203(2):87-95. PubMed ID: 15212143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of mammalian pancreastatins on the pancreatic exocrine secretion.
    Funakoshi A; Miyasaka K; Kitani K; Funakoshi S; Tamamura H; Fujii N; Nakano I; Tatemoto K
    Jpn J Physiol; 1989; 39(6):901-5. PubMed ID: 2632902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of exocrine pancreatic secretion by alpha-adrenergic blocking agents in conscious rats.
    Demol P; Sarles H
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):164-76. PubMed ID: 6104476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.